Product Details
Polymixin B sulphate 5000IU, Chloramphenicol 10mg Dexamethasone 1mg & Phenyl mercuric Nitrate 0.002% Eye Drop. 5 ML
5 ML
Product Description :
POLYMYXIN B SULPHATE 5000 IU + CHLORAMPHENICOL 10 mg + DEXAMETHASONE 1 mg & PHENYLMERCURIC NITRATE 0.002% EYE DROPS – 5 mL
Sterile Ophthalmic Suspension
1. COMPOSITION
Each mL contains:
• Polymyxin B Sulphate 5000 IU.
• Chloramphenicol 10 mg (1% w/v).
• Dexamethasone 1 mg (0.1% w/v).
• Phenylmercuric Nitrate 0.02 mg (0.002% w/v).
• Excipients: As applicable.
• Sterile aqueous vehicle q.s.
2. PHARMACEUTICAL FORM
Sterile ophthalmic suspension for topical ocular administration.
3. THERAPEUTIC CLASS
Ophthalmic Antibacterial – Corticosteroid Combination.
4. INDICATIONS
Polymyxin B Sulphate, Chloramphenicol and Dexamethasone Eye Drops are indicated for steroid-responsive inflammatory conditions of the eye where bacterial infection or a risk of bacterial infection exists, including:
• Inflammatory conditions of the conjunctiva.
• Inflammatory conditions of the eyelids.
• Other steroid-responsive anterior segment inflammatory conditions where antibacterial therapy is appropriate.
Treatment should be guided by the clinical diagnosis and applicable ophthalmic treatment guidelines.
5. CONTRAINDICATIONS
• Hypersensitivity to polymyxin B, chloramphenicol, dexamethasone, phenylmercuric nitrate, or any component of the formulation.
• Viral diseases of the cornea and conjunctiva, including epithelial herpes simplex keratitis.
• Fungal diseases of ocular structures.
• Mycobacterial infections of the eye.
6. DRUG INTERACTIONS
• Concomitant use with other ophthalmic preparations should generally be administered with an appropriate interval between applications.
• Systemic medicines that may interact with chloramphenicol or corticosteroids should be considered when significant systemic absorption is possible.
• The treating physician should review all concomitant medications before use.
7. ADMINISTRATION
For topical ophthalmic use only. Instill the prescribed number of drops into the affected eye(s) according to the approved product information. Shake well before use. Do not touch the dropper tip to the eye or surrounding surfaces. If using other ophthalmic preparations, separate administration by an appropriate interval.
8. STORAGE
Store according to the storage conditions stated on the approved product label. Protect from excessive heat, moisture and light. Keep the container tightly closed when not in use. Do not use if the suspension shows visible particles, unexpected discoloration or other abnormal changes.
Market : international export
Private Label : Available
Registration Support : Available
Regulatory documents : Available on request